Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2026 Mar 2;61(4):517. doi: 10.1038/s41409-026-02809-0

Correction: Can modified lymphodepletion before tisagenlecleucel improve outcome in high-risk patients with large B-cell lymphoma?

Marta Canelo-Vilaseca 1, Mohamad Sabbah 1,2, Caterina Cristinelli 1, Côme Bommier 1,2, Pierre Sesques 3, Mikael Roussel 4, Pierre Bories 5, Vincent Allain 2,6, Amani Ouedrani 6, Ilenia De Bernardis 1, Agathe Vely 1, Pierre Stephan 1, Laetitia Vercellino 2,7, Fabienne Venet 3, Rémi Pescarmona 3, Roch Houot 4, François Vergez 5, Romain de Jorna 8, Isabelle Madelaine 8, Nathalie Parquet 9, Anne C Brignier 9, Jérôme Larghero 2,10, Miryam Mebarki 2,10, Roberta Di Blasi 1, Sophie Caillat-Zucman 2,6, Catherine Thieblemont 1,2,✉
PMCID: PMC13056572  PMID: 41772123

Correction to: Bone Marrow Transplantation 10.1038/s41409-025-02754-4, published online 08 January 2026

In this article, the authors familiy and given names have been interchanged. It should read: Côme (name) BOMMIER (surname) and Roberta (name) DI BLASI (surname).

The original article has been corrected.


Articles from Bone Marrow Transplantation are provided here courtesy of Nature Publishing Group

RESOURCES